Ankur Drugs & Pharma Ltd. - Research Center
531683 ANKURDRUGS Group (T) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 12 | Mar ' 11 | Mar ' 10 | Mar ' 09 | Mar ' 08 | |
|---|---|---|---|---|---|
| Profit before tax | -288.47 | -46.77 | 120.00 | 58.92 | 75.00 |
| Net cashflow-operating activity | 3.20 | -40.54 | 95.44 | 41.87 | 21.50 |
| Net cash used in investing activity | 23.96 | -91.53 | -173.00 | -94.27 | -190.75 |
| Netcash used in fin. activity | -26.92 | 130.15 | 71.15 | 9.18 | 225.74 |
| Net inc/dec in cash and equivlnt | 0.25 | -1.92 | -6.41 | -43.22 | 56.49 |
| Cash and equivalnt begin of year | 1.04 | 2.96 | 15.84 | 59.06 | 2.57 |
| Cash and equivalnt end of year | 1.28 | 1.04 | 9.43 | 15.84 | 59.06 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis